The implementation of evidence-based treatment strategies has improved cost savings and supported value-based care models across three distinct oncology practices within Cedars-Sinai Medical Center.
The regularly utilized methods for determining whether medications should be placed on a hospital center’s formulary addition list do not include the necessary components for value assessments.
The American Society of Clinical Oncology has released new guideline recommendations for the use of larynx-preservation strategies in the treatment of laryngeal cancer.
Approximately 5.6% of new cancer cases worldwide are attributable to the combined effect of diabetes and a high body mass index.
Palliative care utilization among patients with hematologic malignancies remains extremely low.
The use of digital breast tomosynthesis decreased false positive rates while increasing true negative rates when compared with traditional digital mammography.
Non-Hispanic black patients with localized breast cancer who received neoadjuvant chemotherapy experienced worse distant relapse-free survival outcomes when compared with non-Hispanic white patients.
Elderly patients with untreated early-stage triple-negative breast cancer exhibited a higher mortality rate than patients treated with neoadjuvant or adjuvant therapy.
Women with HER2-positive breast cancer who received sequential trastuzumab did not experience a significant difference in overall survival or relapse-free survival when compared with women who received concurrent therapy.
Re-excision rates following breast-conserving surgery have significantly declined in the wake of professional society guideline implementation.